- Voglibose - (https://clinicaltrials.gov/ct2/show/NCT01993927 )
- Voglibose: An Alpha Glucosidase Inhibitor - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/ )
- Efficacy of voglibose in type 2 diabetes - (Â https://pubmed.ncbi.nlm.nih.gov/24798092/ )
- Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy - (https://pubmed.ncbi.nlm.nih.gov/10778865/ )
Voglibose (Vogo (0.2mg)) is an alpha-glucosidase inhibitor, prescribed for diabetes mellitus.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Vogo (0.2mg) - Alembic Chemical Works Co. Ltd.
Vogo (0.2mg) Tablet
Generic : Voglibose
Substitute/Alternative Medication to Vogo (0.2mg)
When is Vogo (0.2mg) prescribed?
It is prescribed for -